Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial - Concepedia

Concepedia

Publication | Open Access

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

DOI Full Paper Access

94

Citations

18

References

2021

Year

Yaseen M. Arabi, Anthony Gordon, Lennie Derde, Alistair Nichol, Srinivas Murthy, Farah Al Beidh, Djillali Annane, Lolowa Al Swaidan, Abi Beane, Richard Beasley,

Intensive Care Medicine

Critical Care MedicineRemap-cap RandomizedIll PatientsCovid-19 PandemicAntiviral TherapyPharmacotherapyAntiviral DrugClinical Infectious DiseaseMedicineCovid-19

References

	Year	Citations

Page 1

Page 1